Company Filing History:
3 out of 71 
1 out of 1 
1 out of 1,309 
Years Active: 2017-2024
Title: Glen Bolton: Innovator in Viral Inactivation Methods
Introduction
Glen Bolton is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of viral inactivation methods. With a total of 5 patents to his name, Bolton's work has had a substantial impact on the production of polypeptides.
Latest Patents
One of Glen Bolton's latest patents focuses on on-column viral inactivation methods. This invention is directed to a method of inactivating viruses that may be present during the production of a polypeptide of interest. Specifically, the method utilizes a low pH and high salt wash solution that effectively inactivates viruses while minimizing recovery loss of the polypeptide. This innovative approach enhances the safety and efficacy of biopharmaceutical products.
Career Highlights
Throughout his career, Glen Bolton has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Bioverativ Therapeutics Inc. and Zepteon, Incorporated. His experience in these organizations has allowed him to develop and refine his expertise in viral inactivation techniques.
Collaborations
Glen Bolton has collaborated with talented individuals in his field, including Keith Selvitelli and Austin Wayne Boesch. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Glen Bolton is a distinguished inventor whose work in viral inactivation methods has made a significant impact on biotechnology. His innovative approaches and collaborations continue to influence the industry positively.